Abstract: A display panel includes a plurality of sub-pixels each corresponding one color. Each sub-pixel includes a plurality of display units and a plurality of driving sub-circuits that are in one-to-one correspondence with the plurality of display units. Each driving sub-circuit is configured to drive a corresponding one of the plurality of display units to be in a bright state or a dark state. The plurality of driving sub-circuits are configured to drive at least two of the plurality of display units to display different display brightness in the bright state.

Abstract: The present disclosure relates to 2-arylamino pyridine, pyrimidine, or triazine derivatives, and the preparation method and use thereof. The 2-arylamino pyridine, pyrimidine, or triazine derivatives may act on certain mutated forms of epidermal growth factor receptor, for example the L858R activating mutant, the delE746_A750 mutant, the Exonl9 deletion activating mutant, and the T790M resistance mutant, so as to be used for treatment and prevention of diseases and medical conditions. The 2-arylamino pyridine, pyrimidine, or triazine derivatives may be used for treatment and prevention of cancer. The present disclosure also relates to a pharmaceutical composition comprising 2-arylamino pyridine, pyrimidine, or triazine derivatives, intermediates useful in the manufacture of 2-arylamino pyridine, pyrimidine, or triazine derivatives, and to methods of treatment of diseases mediated by various different forms of EGFR using 2-arylamino pyridine, pyrimidine, or triazine derivatives.

Abstract: The embodiments of the present disclosure provide a method and system for adjusting a passband width of a filter. The method includes determining an initial passband width, controlling a filter according to the initial passband width to filter signals to be processed, and correcting the initial passband width according to a first frequency at which a peak spectrum line corresponding to the filtered signals is located.

Abstract: The present disclosure provides a temperature-controlled heating panel including: a substrate; at least one heating element provided in a first region on the substrate; at least one temperature sensing element provided in a second region on the substrate and located in a heat radiation area of the at least one heating element; a controller configured to control the temperature of the heat radiation area by using the at least one heating element based on the temperature of the heat radiation area sensed by the at least one temperature sensing element.

Abstract: Embodiments of the present disclosure provide a naked-eye three-dimensional display device and a control method thereof. The naked-eye three-dimensional display device includes a display panel, a liquid crystal grating, a processor and an image collector, wherein, the image collector is configured to obtain first current viewing information and second current viewing information, and send the same to the processor; the processor is configured to receive and store the first and second current viewing information, adjust a width and/or a position of a light transmitting region of the liquid crystal grating according to the first current viewing information, and adjust an output picture of the display panel, according to the second current viewing information and the width and/or the position of the light transmitting region of the liquid crystal grating adjusted.

Abstract: The present disclosure relates to 2-arylamino pyridine, pyrimidine, or triazine derivatives, and the preparation method and use thereof. The 2-arylamino pyridine, pyrimidine, or triazine derivatives may act on certain mutated forms of epidermal growth factor receptor, for example the L858R activating mutant, the delE746_A750 mutant, the Exon19 deletion activating mutant, and the T790M resistance mutant, so as to be used for treatment and prevention of diseases and medical conditions. The 2-arylamino pyridine, pyrimidine, or triazine derivatives may be used for treatment and prevention of cancer. The present disclosure also relates to a pharmaceutical composition comprising 2-arylamino pyridine, pyrimidine, or triazine derivatives, intermediates useful in the manufacture of 2-arylamino pyridine, pyrimidine, or triazine derivatives, and to methods of treatment of diseases mediated by various different forms of EGFR using 2-arylamino pyridine, pyrimidine, or triazine derivatives.

Abstract: The present invention discloses an electronic product and LOGO display method and system thereof, wherein, the LOGO display system comprises an IR emitting and sensing module, a LOGO projection module and a processing module. It emits an IR and detects an IR intensity reflected by a human body through the IR emitting and sensing module; then compares the IR intensity detected by the IR emitting and sensing module with a threshold through the processing module, controls the LOGO projection module to project the LOGO, when the IR intensity is larger than the threshold; it has achieved a personalized display for the LOGO, and attracted an attention from the user to the LOGO, which is more energy-saving and environment-friendly than the prior art of displaying the LOGO continuously after turning on the machine.